04:54 PM EST, 03/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, Generics, General COunsel and Corporate Secretary, on March 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $353,699. Following the Form 4 filing with the SEC, Eydelman has control over a total of 41,620 common shares of the company, with 41,620 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/xslF345X05/wk-form4_1741383777.xml